All drugs come with risk, especially when used irresponsibly
Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta-analysis and subgroup analysis of randomized controlled trials
Some medical conditions, including autoimmune disease like shingles (herpes zoster), rheumatoid arthritis or celiac disease, as well as Lyme disease, some cancers, and several other diseases can also cause or increase the risk of nerve damage, also sometimes referred to as peripheral neuropathy
Researchers at University of North Carolina and other centers are now launching formal studies to assess whether GLP-1 agonists could serve as adjunctive therapy for alcohol-use disorder
This is different from type 1 diabetes, in which the body does not produce insulin at all, and individuals must rely on daily synthetic insulin injections to survive
Patients should understand both the benefits and risks of their medications and be empowered to make choices that align with their health goals and risk tolerance
